Texas Oncology-Medical City Dallas — Dallas, Texas

Texas Oncology-Medical City Dallas is a clinical research site located in Dallas, Texas, United States 75230.

Crixeo Health Trust Score: 79/100 (FAIR). This profile has not yet been claimed by the site owner.

Texas Oncology-Medical City Dallas has participated in 12 clinical trials with 1 currently active.

Therapeutic areas: Breast Cancer, Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma.

Sponsors: Stemline Therapeutics, Inc., Gilead Sciences, Hoffmann-La Roche.

Sponsor Feasibility Report

Trust Score: 79/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Texas Oncology-Medical City Dallas?

Texas Oncology-Medical City Dallas has a Crixeo Trust Score of 79/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Texas Oncology-Medical City Dallas conducted?

Texas Oncology-Medical City Dallas has 12 clinical trials on record, with 1 currently active. Their work covers Breast Cancer, Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma.

Is Texas Oncology-Medical City Dallas accredited by Crixeo Health?

Yes — Texas Oncology-Medical City Dallas holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Texas Oncology-Medical City Dallas?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.